Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Quigley

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Phlebology|June 21, 2015
Serum homocysteine is associated with the severity of primary chronic venous diseaseRoss K Smith, Frank Quigley, Patrik Tosenovsky, et al.
Human Movement Science|May 14, 2009
The influence of a long term exercise program on lower limb movement variability and walking performance in patients with peripheral arterial diseaseRobert G Crowther, Warwick L Spinks, Anthony S Leicht, et al.
Annals of Vascular Surgery|September 20, 2021
Association of Diagnosis of Depression and Small Abdominal Aortic Aneurysm GrowthShivshankar Thanigaimani, James Phie, Frank Quigley, et al.
Jvs-Vascular Science|January 16, 2023
Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growthShivshankar Thanigaimani, James Phie, Frank Quigley, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 11, 2021
The Potential Benefits and Costs of an Intensified Approach to Low Density Lipoprotein Cholesterol Lowering in People with Abdominal Aortic AneurysmDomenico R Nastasi, Richard Norman, Joseph V Moxon, et al.
Scientific Reports|September 5, 2020
Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrateJonathan Golledge, Jenna Pinchbeck, Sophie E Rowbotham, et al.
Journal of Vascular Surgery|September 6, 2020
The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery diseaseDomenico R Nastasi, Joseph V Moxon, Richard Norman, et al.
Frontiers in Cardiovascular Medicine|May 20, 2022
Cohort Study Examining the Association of Optimal Blood Pressure Control at Entry With Infrarenal Abdominal Aortic Aneurysm GrowthDiana Thomas Manapurathe, Joseph Vaughan Moxon, Smriti Murali Krishna, et al.
Journal of the American Heart Association|March 17, 2020
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery DiseaseJonathan Golledge, Sophie Rowbotham, Ramesh Velu, et al.
Trials|January 5, 2017
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trialSophie E Rowbotham, Doug Cavaye, Rene Jaeggi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Phlebology|June 21, 2015
Serum homocysteine is associated with the severity of primary chronic venous diseaseRoss K Smith, Frank Quigley, Patrik Tosenovsky, et al.
Human Movement Science|May 14, 2009
The influence of a long term exercise program on lower limb movement variability and walking performance in patients with peripheral arterial diseaseRobert G Crowther, Warwick L Spinks, Anthony S Leicht, et al.
Annals of Vascular Surgery|September 20, 2021
Association of Diagnosis of Depression and Small Abdominal Aortic Aneurysm GrowthShivshankar Thanigaimani, James Phie, Frank Quigley, et al.
Jvs-Vascular Science|January 16, 2023
Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growthShivshankar Thanigaimani, James Phie, Frank Quigley, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 11, 2021
The Potential Benefits and Costs of an Intensified Approach to Low Density Lipoprotein Cholesterol Lowering in People with Abdominal Aortic AneurysmDomenico R Nastasi, Richard Norman, Joseph V Moxon, et al.
Scientific Reports|September 5, 2020
Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrateJonathan Golledge, Jenna Pinchbeck, Sophie E Rowbotham, et al.
Journal of Vascular Surgery|September 6, 2020
The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery diseaseDomenico R Nastasi, Joseph V Moxon, Richard Norman, et al.
Frontiers in Cardiovascular Medicine|May 20, 2022
Cohort Study Examining the Association of Optimal Blood Pressure Control at Entry With Infrarenal Abdominal Aortic Aneurysm GrowthDiana Thomas Manapurathe, Joseph Vaughan Moxon, Smriti Murali Krishna, et al.
Journal of the American Heart Association|March 17, 2020
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery DiseaseJonathan Golledge, Sophie Rowbotham, Ramesh Velu, et al.
Trials|January 5, 2017
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trialSophie E Rowbotham, Doug Cavaye, Rene Jaeggi, et al.
Pageof 4